• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
No histology for diminutive duodenal neuroendocrine tumors: Is it safe?微小十二指肠神经内分泌肿瘤无需组织学检查:这样安全吗?
Endosc Int Open. 2019 Feb;7(2):E308-E309. doi: 10.1055/a-0650-4478. Epub 2019 Feb 8.
2
Endoscopic banding without resection (BWR) technique for treatment of diminutive neuroendocrine tumors in the duodenum.内镜下不切除套扎术(BWR)治疗十二指肠微小神经内分泌肿瘤的技术
Endosc Int Open. 2019 Feb;7(2):E302-E307. doi: 10.1055/a-0684-9563. Epub 2019 Feb 8.
3
The band and slough technique is effective for management of diminutive type 1 gastric and duodenal neuroendocrine tumors.圈套切除和黏膜剥脱术对于治疗微小的1型胃和十二指肠神经内分泌肿瘤有效。
Endosc Int Open. 2020 Jun;8(6):E717-E721. doi: 10.1055/a-1119-6698. Epub 2020 May 25.
4
Endoscopic Management of Diminutive Duodenal Neuroendocrine Tumors.十二指肠神经内分泌肿瘤的内镜治疗。
J Gastrointest Cancer. 2021 Jun;52(2):448-453. doi: 10.1007/s12029-020-00577-8. Epub 2021 Jan 20.
5
Endoscopic full-thickness resection of well-differentiated T2 neuroendocrine tumors in the duodenal bulb: a case series.十二指肠球部高分化T2神经内分泌肿瘤的内镜全层切除术:病例系列
VideoGIE. 2022 Mar 2;7(5):196-199. doi: 10.1016/j.vgie.2021.12.013. eCollection 2022 May.
6
Cap-Assisted Endoscopic Mucosal Resection for Rectal Neuroendocrine Tumors: An Effective Option.帽辅助内镜黏膜切除术治疗直肠神经内分泌肿瘤:一种有效的选择。
GE Port J Gastroenterol. 2022 Aug 26;30(2):107-114. doi: 10.1159/000525964. eCollection 2023 Mar.
7
A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.对于许多小的、散发性、低级别、非壶腹、无功能的十二指肠神经内分泌肿瘤患者,定期内镜监测的“观察与等待”策略是安全的。
Neuroendocrinology. 2021;111(8):764-774. doi: 10.1159/000511613. Epub 2020 Sep 16.
8
Current status of the role of endoscopy in evaluation and management of gastrointestinal and pancreatic neuroendocrine tumors.内镜在胃肠道和胰腺神经内分泌肿瘤的评估和管理中的作用的现状。
Indian J Gastroenterol. 2023 Apr;42(2):158-172. doi: 10.1007/s12664-023-01362-8. Epub 2023 May 2.
9
Endoscopic submucosal resection using a ligation device without injection for duodenal neuroendocrine tumors.内镜黏膜下剥离术联合结扎装置治疗十二指肠神经内分泌肿瘤,无需注射。
Surg Endosc. 2019 Jun;33(6):2008-2014. doi: 10.1007/s00464-018-06642-5. Epub 2019 Jan 2.
10
Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors.内镜黏膜切除术治疗小十二指肠神经内分泌肿瘤的疗效
Surg Laparosc Endosc Percutan Tech. 2015 Oct;25(5):e134-9. doi: 10.1097/SLE.0000000000000192.

本文引用的文献

1
Endoscopic banding without resection (BWR) technique for treatment of diminutive neuroendocrine tumors in the duodenum.内镜下不切除套扎术(BWR)治疗十二指肠微小神经内分泌肿瘤的技术
Endosc Int Open. 2019 Feb;7(2):E302-E307. doi: 10.1055/a-0684-9563. Epub 2019 Feb 8.
2
The Theory and Practice of Pancreatic Surgery in France.法国胰腺外科学理论与实践
Ann Surg. 2017 Nov;266(5):797-804. doi: 10.1097/SLA.0000000000002399.
3
Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy.十二指肠和壶腹类癌肿瘤:大小预示着淋巴结清扫的必要性。
J Gastrointest Surg. 2017 Aug;21(8):1262-1269. doi: 10.1007/s11605-017-3448-4. Epub 2017 May 17.
4
Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.散发性十二指肠和壶腹神经内分泌肿瘤的内镜治疗
Endoscopy. 2016 Nov;48(11):979-986. doi: 10.1055/s-0042-112570. Epub 2016 Aug 5.
5
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.ENETS胃十二指肠神经内分泌肿瘤共识指南更新
Neuroendocrinology. 2016;103(2):119-24. doi: 10.1159/000443168. Epub 2016 Jan 19.
6
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.《欧洲神经内分泌肿瘤学会功能性胰腺神经内分泌肿瘤和非功能性胰腺神经内分泌肿瘤患者管理共识指南更新》
Neuroendocrinology. 2016;103(2):153-71. doi: 10.1159/000443171. Epub 2016 Jan 5.
7
Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?十二指肠神经内分泌肿瘤发病率上升:是惰性疾病的偶然发现?
Surgery. 2015 Aug;158(2):466-71. doi: 10.1016/j.surg.2015.03.042. Epub 2015 May 23.
8
A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.一种改良的十二指肠神经内分泌肿瘤分期方案能更好地界定淋巴结转移风险和无病生存期。
Am Surg. 2014 Aug;80(8):821-6.
9
Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study.十二指肠类癌肿瘤的内镜切除术:一项多中心回顾性研究。
J Gastroenterol Hepatol. 2014 Feb;29(2):318-24. doi: 10.1111/jgh.12390.
10
Management strategy for small duodenal carcinoid tumors: does conservative management with close follow-up represent an alternative to endoscopic treatment?十二指肠小类癌肿瘤的治疗策略:密切随访的保守治疗是否可以替代内镜治疗?
Digestion. 2013;87(4):247-53. doi: 10.1159/000349958. Epub 2013 Jun 6.

微小十二指肠神经内分泌肿瘤无需组织学检查:这样安全吗?

No histology for diminutive duodenal neuroendocrine tumors: Is it safe?

作者信息

Walter Thomas

机构信息

Hospices Civils de Lyon, Hôpital Edouard Herriot, Department d'Oncologie Médicale, Lyon, France.

出版信息

Endosc Int Open. 2019 Feb;7(2):E308-E309. doi: 10.1055/a-0650-4478. Epub 2019 Feb 8.

DOI:10.1055/a-0650-4478
PMID:30747160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6368482/
Abstract

For the management of diminutive duodenal neuroendocrine tumors (d-NETs), Harshit et al. have proposed - in the work accompanying this editorial - an interesting approach, the endoscopic banding without resection (BWR) technique. Given the risks associated with classic endoscopic resections and surgical procedures, and the likely favorable natural history of diminutive d-NETs, BWR may be an option for these selected patients with a very low risk of LN + and recurrence. However, a close follow-up (endoscopic, EUS and thoraco-abdominal CT scan) is then required to guarantee the safety of this policy.

摘要

对于微小十二指肠神经内分泌肿瘤(d-NETs)的管理,Harshit等人在本社论的相关工作中提出了一种有趣的方法,即内镜下不切除的套扎术(BWR)技术。鉴于经典内镜切除术和外科手术相关的风险,以及微小d-NETs可能良好的自然病程,BWR对于这些淋巴结转移(LN+)和复发风险极低的特定患者可能是一种选择。然而,随后需要密切随访(内镜检查、超声内镜和胸腹CT扫描)以确保该策略的安全性。